Overview of Dr. Mokhtari
Dr. Sepideh Mokhtari is a neurologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Texas AM Health Science Center College of Medicine and has been in practice 11 years. She is one of 35 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Neurology. She has more than 10 publications and over 150 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Fax+1 813-745-8495
Education & Training
- Methodist Hospital (Houston)Residency, Neurology, 2011 - 2014
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2010 - 2011
- Texas A&M; Health Science Center College of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2016 - 2025
- NY State Medical License 2014 - 2017
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease Start of enrollment: 2020 Dec 10
Publications & Presentations
PubMed
- 11 citationsRituximab for Immune Checkpoint Inhibitor Myasthenia GravisNeha Verma, Muhammad Jaffer, Yolanda Pina, Edwin Peguero, Sepideh Mokhtari
Cureus. 2021-07-12 - 3 citationsAssessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors.Solmaz Sahebjam, Dexter G Stallworth, Sepideh Mokhtari, Nam D. Tran, John A. Arrington
Cancer Control. 2017-04-01 - 29 citationsClinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T. Rizk, Homan Mohammadi, Brittany Evernden, Sepideh Mokhtari
Breast Cancer Research and Treatment. 2019-03-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: